C4 Therapeutics: Q3 Earnings Insights

C4 Therapeutics CCCC reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

C4 Therapeutics beat estimated earnings by 2.99%, reporting an EPS of $-0.65 versus an estimate of $-0.67.

Revenue was down $1.75 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.13 which was followed by a 9.15% increase in the share price the next day.

Here's a look at C4 Therapeutics's past performance:

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for C4 Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.